Scott T. Rottinghaus insider trades

Open-market stock purchases and sales by Scott T. Rottinghaus, Chief Medical Officer at Enanta Pharmaceuticals Inc, from SEC Form 4 filings since Aug 8, 2022.

Recent trades

DateStockTradeValue
Aug 8, 2026ENTA Enanta Pharmaceuticals IncSold (not open market)$19.6K
Feb 12, 2026ENTA Enanta Pharmaceuticals IncBought (not open market)—
Feb 12, 2026ENTA Enanta Pharmaceuticals IncBought (not open market)—
Feb 12, 2026ENTA Enanta Pharmaceuticals IncSold (not open market)$48.6K
Dec 5, 2025ENTA Enanta Pharmaceuticals IncSold$11.4K
Nov 25, 2025ENTA Enanta Pharmaceuticals IncBought (not open market)—

Companies traded

  • ENTA Enanta Pharmaceuticals Inc: 6 sales, last Aug 8, 2026

Get free alerts when Scott T. Rottinghaus files a new trade →